ELOVL2-AS1 suppresses tamoxifen resistance by sponging miR-1233-3p in breast cancer
Volume 18, Issue 1, December 2023 .
Source: Epigenetics - Category: Genetics & Stem Cells Authors: Hyeon Woo KimMinjae BaekSanghyun JungSiyeon JangHyeonjin LeeSeung-Hoon YangBeom Seok KwakSun Jung Kima Department of Life Science, Dongguk University-Seoul, Goyang, Republic of Koreab Department of Biomedical Engineering, Dongguk University-Seoul, Goyang, Source Type: research
More News: Biomedical Engineering | Breast Cancer | Cancer | Cancer & Oncology | Genetics | Science | Tamoxifen